TVM CAPITAL
TVM Capital is a global venture and growth capital firm that aims to finance select biopharmaceutical and medical device companies. TVM Capital was founded in 1983 and is based Munich, Bavaria.
TVM CAPITAL
Industry:
Health Care Medical Venture Capital
Founded:
1983-01-01
Status:
Active
Contact:
+49 (89) 998 992-00
Technology used in webpage:
Host Europe
Similar Organizations
Apollo Health Ventures
Apollo Health Ventures is a venture capital firm investing in seed and early stage biotechnology companies.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Section 32
Section 32 is a venture capital fund that invests at the cutting edge of technology, healthcare, and life sciences.
Current Advisors List
Board_member
2009-09-01
Advisor
Board_member
2000-01-01
Current Employees Featured
Marc Riviere General Partner @ TVM Capital
General Partner
2013-08-01
Hubert Birner General Partner @ TVM Capital
General Partner
2000-01-01
Stefan Fischer General Partner and Chief Financial Officer @ TVM Capital
General Partner and Chief Financial Officer
Rolf Starck Partner @ TVM Capital
Partner
Mirko Scherer Managing Partner @ TVM Capital
Managing Partner
Friedrich Bornikoel Managing Director @ TVM Capital
Managing Director
Christoph Schröder General Partner @ TVM Capital
General Partner
Luc Marengere Managing Partner @ TVM Capital
Managing Partner
2012-03-01
Josef Moosholzer Head of Finance @ TVM Capital
Head of Finance
Hui Hsing Ma General Partner @ TVM Capital
General Partner
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2023-02-09 | Lamab Biologics | TVM Capital investment in Venture Round - Lamab Biologics | 25 M USD |
| 2015-04-29 | Rapid Micro Biosystems | TVM Capital investment in Series C - Rapid Micro Biosystems | 25 M USD |
| 2014-06-23 | Definiens | TVM Capital investment in Venture Round - Definiens | 15 M EUR |
| 2014-05-16 | Proteon Therapeutics | TVM Capital investment in Series D - Proteon Therapeutics | 45 M USD |
| 2014-04-04 | Rapid Micro Biosystems | TVM Capital investment in Venture Round - Rapid Micro Biosystems | 6 M USD |
| 2014-03-20 | invendo medical | TVM Capital investment in Venture Round - invendo medical | 28 M USD |
| 2013-11-20 | Argos Therapeutics | TVM Capital investment in Series E - Argos Therapeutics | 17.5 M USD |
| 2013-10-23 | F-Star Therapeutics | TVM Capital investment in Series A - F-Star Therapeutics | 9.4 M USD |
| 2013-06-26 | Rapid Micro Biosystems | TVM Capital investment in Series B - Rapid Micro Biosystems | 32.6 M USD |
| 2012-10-01 | Definiens | TVM Capital investment in Venture Round - Definiens | 10 M EUR |
More informations about "TVM Capital"
About us - TVM Capital Life Science Venture Capital
TVM Capital Life Science has emerged as one of the leading international venture capital firms in the field. TVM strategically refocused in 2012 to best exploit untapped industry potential. To …See details»
TVM Capital - Crunchbase Investor Profile & Investments
TVM Capital Healthcare also announced a USD 35 million investment into Boston Oncology Arabia. Learn more. Investment Thesis . Overview. TVM Capital invests in early to late-stage biotechnology, pharmaceutical, and healthcare …See details»
Strategy & Approach - TVM Capital Life Science …
Just 1.5 years after TVM’s initial investment and a total investment by TVM of US$11 million, Lilly acquired Aurka Pharma based on Phase 1 data. The deal was executed in under 10 weeks and included US$110 million upfront and up …See details»
TVM Capital Life Science - Crunchbase
TVM Capital Life Science may be growing as it has led a €23 million Series C financing round for a medical reporting technology company and co-led a $16 million Series A financing round for …See details»
TVM Capital Life Science - LinkedIn
TVM Capital Life Science | 4,819 followers on LinkedIn. Leading international VC providing capital and expertise to support breakthrough therapies and medical products | TVM is a leading …See details»
TVM Capital Life Science - LinkedIn
TVM is a leading international venture capital firm focused on investing in life science innovations. The company has a highly experienced transatlantic investment team and approximately $900 ...See details»
Home - TVM Capital Healthcare
We focus on healthcare growth capital investing with a focus on returns & impact. We invest equity into transformational healthcare companies with ambitious growth plans in our key target regions. TVM Capital Healthcare is a highly …See details»
TVM Capital Life Science Leads €23 Million Series C Financing …
Apr 22, 2024 MUNICH, Germany and MONTREAL, April 22, 2024 (GLOBE NEWSWIRE) -- TVM Capital Life Science (“TVM”), a leading international venture capital firm focused on …See details»
TVM Capital Life Science - Investments, Portfolio & Company Exits
TVM Capital Life Science 's most notable exits include Centogene, Acer Therapeutics, and CoLucid Pharmaceuticals. TVM Capital Life Science has acquired ImmunoRx Pharma on Jan …See details»
TVM Capital Healthcare - LinkedIn
TVM Capital Healthcare | 6,079 followers on LinkedIn. We invest growth capital in healthcare companies in the MENA and SEA regions with a focus on returns and impact | TVM Capital …See details»
Team Archive - TVM Capital Life Science Venture Capital
Jan 26, 2024 Dr. Amy Kao joined TVM Capital in April 2023. Prior to TVM, Amy focused on building and funding healthtech opportunities at Oxford Science Enterprises, the largest …See details»
Portfolios Archive - TVM Capital Life Science Venture Capital
“TVM incorporates teamwork into its culture of working with biotech companies, creating a strong framework for successful collaboration.” Michael Salzmann, PhD, CEO, AL-S Pharma “TVM …See details»
TVM Capital Life Science Announces Substantially ... - Newswire
Oct 27, 2020 TVM Capital Life Science: Stefan Fischer, Managing Partner (Finance), ... Organization Profile. TVM Capital Life Science. Contact Cision. 866-245-2317 from 8 AM - 10 …See details»
TVM Capital - Investments, Portfolio & Company Exits - Crunchbase
TVM Capital 's most notable exits include Arteris, Bluebird Bio, and TME Pharma. Which industries has this organization had the most exits in? Show . Arteris Arteris provides System …See details»
TVM Capital Life Science Announces €8 Million Investment in myo …
Jan 31, 2024 TVM Life Science Management GmbH. MUNICH, Germany and MONTREAL, Jan. 31, 2024 (GLOBE NEWSWIRE) -- TVM Capital Life Science (“TVM”), a leading transatlantic …See details»
TVM News Archives - TVM Capital Life Science Venture Capital
Oct 30, 2024 TVM and Portfolio Companies Showcase Transformative Partnerships and Industry Trends in Panel discussions and Presentations . Munich, Germany and Montreal, …See details»
TVM Capital Healthcare - Crunchbase
TVM Capital Healthcare is a highly focused private equity and growth capital firm focusing on making growth capital and buyout investments in companies that are already, or aspire to …See details»
Time Value of Money (TVM): A Primer | HBS Online
Jun 16, 2022 What Is the Time Value of Money? The time value of money (TVM) is a core financial principle that states a sum of money is worth more now than in the future.. In the …See details»
News & Events - TVM Capital Life Science Venture Capital
TVM Capital Life Science will take part in the 24th Annual Biotech in Europe Forum September 25-26, 2024 in Basel, Switzerland at the Mövenpick Hotel. Basel, Switzerland at the …See details»